STRATA Skin Sciences, Inc. (SSKN)
NASDAQ: SSKN · Real-Time Price · USD
0.3163
-0.0287 (-8.32%)
At close: Feb 17, 2026, 4:00 PM EST
0.2625
-0.0538 (-17.01%)
After-hours: Feb 17, 2026, 7:59 PM EST
STRATA Skin Sciences Revenue
STRATA Skin Sciences had revenue of $6.93M in the quarter ending September 30, 2025, a decrease of -21.23%. This brings the company's revenue in the last twelve months to $30.98M, down -5.19% year-over-year. In the year 2024, STRATA Skin Sciences had annual revenue of $33.56M with 0.61% growth.
Revenue (ttm)
$30.98M
Revenue Growth
-5.19%
P/S Ratio
0.05
Revenue / Employee
$292,264
Employees
106
Market Cap
1.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.56M | 204.00K | 0.61% |
| Dec 31, 2023 | 33.36M | -2.80M | -7.75% |
| Dec 31, 2022 | 36.16M | 6.18M | 20.63% |
| Dec 31, 2021 | 29.98M | 6.89M | 29.83% |
| Dec 31, 2020 | 23.09M | -8.50M | -26.90% |
| Dec 31, 2019 | 31.59M | 1.73M | 5.80% |
| Dec 31, 2018 | 29.86M | -1.91M | -6.01% |
| Dec 31, 2017 | 31.76M | 1.06M | 3.44% |
| Dec 31, 2016 | 30.71M | 12.21M | 66.03% |
| Dec 31, 2015 | 18.50M | 17.58M | 1,921.31% |
| Dec 31, 2014 | 915.00K | 379.00K | 70.71% |
| Dec 31, 2013 | 536.00K | 258.00K | 92.81% |
| Dec 31, 2012 | 278.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.17M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
| Profusa | 75.00K |
SSKN News
- 13 hours ago - STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis - GlobeNewsWire
- 6 days ago - Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences - GlobeNewsWire
- 2 months ago - STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico - GlobeNewsWire
- 3 months ago - STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion - GlobeNewsWire
- 3 months ago - STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update - GlobeNewsWire
- 4 months ago - Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides - GlobeNewsWire
- 4 months ago - Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis - GlobeNewsWire